Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
NCT01153282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2020-03-10
Summary
Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
Conditions
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Principal Investigators
-
Angela DeMichele, MD · Abramson Cancer Center at Penn Medicine
Eligibility
- Min Age
- 21 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-06-30
- Primary Completion
- 2012-05-31
- Completion
- 2012-05-31
Countries
- United States
Study Locations
More Related Trials
-
Assessment of Paclitaxel-Induced Neuropathy
NCT01953159 ·Status: ACTIVE_NOT_RECRUITING
-
Chemotherapy-Induced Peripheral Neuropathy Survey
NCT01016028 ·Status: WITHDRAWN
-
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
NCT00353483 ·Status: RECRUITING
-
Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
NCT00155259 ·Status: COMPLETED ·Phase: PHASE2
-
Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients
NCT03872141 ·Status: COMPLETED
-
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer
NCT00308178 ·Status: COMPLETED ·Phase: NA
-
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer
NCT00110695 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel (Phyxol) and Cisplatin as First-line Chemotherapy for Metastatic Breast Cancer
NCT00154882 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer
NCT00365365 ·Status: COMPLETED ·Phase: PHASE2
-
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
NCT05189535 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
NCT03611985 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients
NCT05889988 ·Status: ACTIVE_NOT_RECRUITING
-
Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
NCT00875238 ·Status: COMPLETED
-
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00004888 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery
NCT00251329 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
NCT00214864 ·Status: COMPLETED ·Phase: PHASE2
-
Mathematical Modeling to Predict Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT03983538 ·Status: COMPLETED
-
Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
NCT00006104 ·Status: COMPLETED ·Phase: PHASE2
-
Endocrine Disruptors and Life STILe in Breast Cancer Development
NCT05748353 ·Status: ACTIVE_NOT_RECRUITING
-
Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy
NCT07307911 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
NCT02214381 ·Status: COMPLETED ·Phase: PHASE3
-
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
NCT00003035 ·Status: COMPLETED ·Phase: PHASE2
-
Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer
NCT00005908 ·Status: COMPLETED ·Phase: PHASE2
-
SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial
NCT00002900 ·Status: COMPLETED
-
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00003032 ·Status: COMPLETED ·Phase: PHASE3